Secura Bio, Inc.
SAN DIEGO, CA · Founded 2019 · CIK 0001771442 · Biotech · Private
Monoclonal antibodies and immunotherapeutics for autoimmune and inflammatory diseases
securabio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $50M
- 1 Form D · Apr 2019
- 90 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 1 granted · 14 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $50,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2329 | CALLENTIS CONSULTING GROUP LLC | — | — |
| 2330 | Protein Dynamic Solutions, Inc. | — | $3.4M |
| 2331 | GlycoEra | — | — |
| 2332 | Secura Bio, Inc. | — | $50M |
| 2333 | NEMAGEN DISCOVERIES INC | — | — |
| 2334 | NEMAMETRIX, INC | — | $9.4M |
| 2335 | TERAIMMUNE, INC. | — | $3.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Juan EstruchExecutive Officer
- Joseph LimberDirector · Executive Officer
- Brett LundDirector · Executive Officer
- Mark SpringDirector · Executive Officer
Patents
- Treatment Of Cancers Using PI3 Kinase Isoform Modulatorsgranted
- Methods Of Treating Peripheral T-cell Lymphomaapplication
- Methods Of Making Cellular Therapiesapplication
- Combination Therapiesapplication
- Panobinostat Dosages For Multiple Myelomaapplication
- Panobinostat Dosages For Multiple Myelomaapplication
- Panobinostat Dosages For Multiple Myelomaapplication
- Panobinostat Dosages For Multiple Myelomaapplication
- Treatment Of Cancers Using PI3 Kinase Isoform Modulatorsapplication
- Methods Of Treating Brain Cancer With Panobinostatapplication
- Methods Of Making Cellular Therapiesapplication
- Combination Therapiesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.